NASDAQ:FRTX Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis → Your $250 MarketBeat account credit is about to expire (From MarketBeat) (Ad) Free FRTX Stock Alerts $0.91 0.00 (0.00%) (As of 10:48 AM ET) Add Compare Share Share Today's Range$0.91▼$0.9250-Day Range$0.87▼$1.0052-Week Range$0.45▼$1.10Volume1,008 shsAverage Volume17,301 shsMarket Capitalization$5.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Fresh Tracks Therapeutics alerts: Email Address Ad MarketBeatWe just added a $250 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $250 off your 2024 subscription. Claim Your Discount Here About Fresh Tracks Therapeutics Stock (NASDAQ:FRTX)Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.Read More FRTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FRTX Stock News HeadlinesApril 27, 2024 | americanbankingnews.comFresh Tracks Therapeutics (NASDAQ:FRTX) Trading Down 1.1%April 25, 2024 | investing.comExploration capital buys fresh tracks therapeutics shares worth over $19kApril 29, 2024 | MarketBeat (Ad)We just added a $250 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $250 off your 2024 subscription. April 13, 2024 | investing.comExploration capital purchases Fresh Tracks Therapeutics stock worth $2,805February 16, 2024 | finanznachrichten.deFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15thFebruary 14, 2024 | finance.yahoo.comFresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15thFebruary 14, 2024 | globenewswire.comFresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15thJanuary 3, 2024 | morningstar.comFresh Tracks Therapeutics IncApril 29, 2024 | MarketBeat (Ad)We just added a $250 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $250 off your 2024 subscription. December 27, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15thDecember 20, 2023 | finanznachrichten.deFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Announces Listing on OTC Pink MarketDecember 19, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Listing on OTC Pink MarketDecember 18, 2023 | msn.comWhy Fresh Tracks Therapeutics (FRTX) Shares Are VolatileDecember 15, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of StockholdersDecember 1, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of StockholdersNovember 17, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Adjournment of Special Meeting of StockholdersNovember 13, 2023 | finanznachrichten.deFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comFresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 12, 2023 | morningstar.comFresh Tracks Therapeutics Inc FRTXOctober 25, 2023 | finance.yahoo.comFresh Tracks Therapeutics, Inc. (VCC.F)September 19, 2023 | marketwatch.comFresh Tracks Therapeutics Plans to Liquidate, Shares Surge 43%September 19, 2023 | nasdaq.comFresh Tracks Therapeutics Approves Plan Of LiquidationSeptember 19, 2023 | msn.comFresh Track Therapeutics board approves plan to liquidate companySeptember 19, 2023 | finance.yahoo.comFresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and DissolutionJuly 22, 2023 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.01%July 21, 2023 | msn.comWall Street Set to Open Higher, Investors Look to End Week on Positive NoteJuly 21, 2023 | finance.yahoo.comFresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from BotanixSee More Headlines Receive FRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresh Tracks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2024Today4/29/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:FRTX CUSIPN/A CIK819050 WebN/A Phone(720) 505-4755Fax858-646-1150Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,690,000.00 Net Margins-91.29% Pretax Margin-71.12% Return on Equity-60.83% Return on Assets-50.73% Debt Debt-to-Equity RatioN/A Current Ratio6.98 Quick Ratio6.98 Sales & Book Value Annual Sales$8.01 million Price / Sales0.68 Cash FlowN/A Price / Cash FlowN/A Book Value$1.66 per share Price / Book0.55Miscellaneous Outstanding Shares5,970,000Free Float5,959,000Market Cap$5.43 million OptionableNot Optionable Beta0.39 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Albert Nicholas Marchio II (Age 72)CEO, CFO, Secretary & Chairman Aron Aizenstat M.B.A.P.M.P., Vice President of Corporate Development & OperationsMr. Aaron Fox-Collis CPAVP of Finance & Chief Accounting OfficerMs. Sue FattorHead of Human ResourceDr. James S. McElvain Ph.D.Interim Head of CMC DevelopmentKey CompetitorsPalisade BioNASDAQ:PALIChromocell TherapeuticsNYSE:CHROFinch Therapeutics GroupNASDAQ:FNCHCreative Medical TechnologyNASDAQ:CELZTitan PharmaceuticalsNASDAQ:TTNPView All CompetitorsInsidersExploration Capital, LlcBought 47,000 shares on 12/20/2023Total: $39,480.00 ($0.84/share)Aaron Fox-CollisSold 74 sharesTotal: $67.34 ($0.91/share)Aaron Fox-ColisSold 36 sharesTotal: $30.60 ($0.85/share)View All Insider Transactions FRTX Stock Analysis - Frequently Asked Questions How have FRTX shares performed in 2024? Fresh Tracks Therapeutics' stock was trading at $0.8791 at the beginning of the year. Since then, FRTX stock has increased by 3.5% and is now trading at $0.9101. View the best growth stocks for 2024 here. When is Fresh Tracks Therapeutics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our FRTX earnings forecast. How were Fresh Tracks Therapeutics' earnings last quarter? Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) issued its earnings results on Friday, March, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter. Fresh Tracks Therapeutics had a negative net margin of 91.29% and a negative trailing twelve-month return on equity of 60.83%. How do I buy shares of Fresh Tracks Therapeutics? Shares of FRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FRTX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh Tracks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
